These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26053729)

  • 41. Nonneoplastic Neuroma After Radical Prostatectomy Is Not a Mimicker of Lymph Node Metastases on 68Ga-PSMA Ligand PET/CT.
    Derlin T; Schumacher U; Bengel FM
    Clin Nucl Med; 2016 Oct; 41(10):785-6. PubMed ID: 27556791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
    Kulkarni SC; Sundaram PS; Padma S
    Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.
    Keidar Z; Gill R; Goshen E; Israel O; Davidson T; Morgulis M; Pirmisashvili N; Ben-Haim S
    Cancer Imaging; 2018 Nov; 18(1):39. PubMed ID: 30382889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of
    Zhang Q; Zang S; Zhang C; Fu Y; Lv X; Zhang Q; Deng Y; Zhang C; Luo R; Zhao X; Wang W; Wang F; Guo H
    J Transl Med; 2017 Nov; 15(1):230. PubMed ID: 29115970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 68Ga-PSMA PET/MR-Positive, Histopathology-Proven Prostate Cancer in a Patient With Negative Multiparametric Prostate MRI.
    Muehlematter UJ; Rupp NJ; Mueller J; Eberli D; Burger IA
    Clin Nucl Med; 2018 Aug; 43(8):e282-e284. PubMed ID: 29847319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice.
    Krohn T; Verburg FA; Pufe T; Neuhuber W; Vogg A; Heinzel A; Mottaghy FM; Behrendt FF
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):210-4. PubMed ID: 25248644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy.
    Vadi SK; Kumar R; Mittal BR; Parihar AS; Singh SK
    Clin Nucl Med; 2018 Apr; 43(4):276-278. PubMed ID: 29465493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of additional
    Bräuer A; Rahbar K; Konnert J; Bögemann M; Stegger L
    Nuklearmedizin; 2017 Feb; 56(1):14-22. PubMed ID: 28074210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frusemide aids diagnostic interpretation of
    Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. One-Stop-Shop Whole-Body
    Thalgott M; Düwel C; Rauscher I; Heck MM; Haller B; Gafita A; Gschwend JE; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2018 Dec; 59(12):1850-1856. PubMed ID: 29794224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The accuracy of
    Öbek C; Doğanca T; Demirci E; Ocak M; Kural AR; Yıldırım A; Yücetaş U; Demirdağ Ç; Erdoğan SM; Kabasakal L;
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1806-1812. PubMed ID: 28624849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.
    Chan M; Schembri GP; Hsiao E
    Clin Nucl Med; 2017 Jan; 42(1):56-57. PubMed ID: 27764044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlations of the
    Karyagar SS; Karyagar S; Guven O
    Hell J Nucl Med; 2020; 23(2):120-124. PubMed ID: 32716402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer.
    Snow HA; Hofman MS; Mitchell CA; Gyorki DE; Smith MJF
    Clin Nucl Med; 2018 Jul; 43(7):509-511. PubMed ID: 29742609
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM
    Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
    Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
    Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
    Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
    J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate penile metastasis: Incidence and imaging pattern on
    Tatkovic A; McBean R; Schoeman J; Wong D
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):499-504. PubMed ID: 32449823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
    Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
    Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
    Lin CY; Lee MT; Lin CL; Kao CH
    Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.